Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)
Others
Ratios

Addex Therapeutics (ADXN) Profit After Tax: 2022-2025

Historic Profit After Tax for Addex Therapeutics (ADXN) over the last 3 years, with Jun 2025 value amounting to -$2.2 million.

  • Addex Therapeutics' Profit After Tax fell 115.62% to -$2.2 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$9,430.7 billion, marking a year-over-year decrease of 208.65%. This contributed to the annual value of $8.0 million for FY2024, which is 168.24% up from last year.
  • As of Q2 2025, Addex Therapeutics' Profit After Tax stood at -$2.2 million, which was down 35.75% from -$1.6 million recorded in Q1 2025.
  • In the past 5 years, Addex Therapeutics' Profit After Tax registered a high of $8,679.9 billion during Q4 2023, and its lowest value of -$9,430.7 billion during Q4 2024.
  • Its 3-year average for Profit After Tax is -$75.1 billion, with a median of -$2.4 million in 2023.
  • Per our database at Business Quant, Addex Therapeutics' Profit After Tax soared by 40,194,262.97% in 2023 and then plummeted by 208.65% in 2024.
  • Over the past 4 years, Addex Therapeutics' Profit After Tax (Quarterly) stood at -$21.6 million in 2022, then spiked by 40,194,262.97% to $8,679.9 billion in 2023, then crashed by 208.65% to -$9,430.7 billion in 2024, then plummeted by 115.62% to -$2.2 million in 2025.
  • Its last three reported values are -$2.2 million in Q2 2025, -$1.6 million for Q1 2025, and -$9,430.7 billion during Q4 2024.